Cornercap Investment Counsel Inc United Therapeutics Corp Transaction History

Cornercap Investment Counsel Inc

  • $329 Million
  • Q3 2024

A detailed history of Cornercap Investment Counsel Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 2,027 shares of UTHR stock, worth $727,551. This represents 0.22% of its overall portfolio holdings.

Number of Shares
2,027
Previous 5,284 61.64%
Holding current value
$727,551
Previous $1.68 Million 56.86%
% of portfolio
0.22%
Previous 0.28%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
SELL
$311.04 - $363.55 $1.01 Million - $1.18 Million
-3,257 Reduced 61.64%
2,027 $726,000
Q2 2024

Aug 08, 2024
SELL
$228.26 - $319.04 $19,173 - $26,799
-84 Reduced 1.56%
5,284 $1.68 Million
Q1 2024

May 10, 2024
BUY
$210.76 - $249.51 $47,421 - $56,139
225 Added 4.37%
5,368 $1.23 Million
Q4 2023

Jan 30, 2024
SELL
$214.88 - $256.94 $859 - $1,027
-4 Reduced 0.08%
5,143 $1.13 Million
Q3 2023

Nov 13, 2023
SELL
$211.82 - $248.24 $13,132 - $15,390
-62 Reduced 1.19%
5,147 $1.16 Million
Q1 2023

May 11, 2023
BUY
$212.99 - $276.17 $62,619 - $81,193
294 Added 5.98%
5,209 $1.17 Million
Q4 2022

Feb 13, 2023
SELL
$205.95 - $280.43 $199,153 - $271,175
-967 Reduced 16.44%
4,915 $1.37 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $177,887 - $213,648
-875 Reduced 12.95%
5,882 $1.23 Million
Q2 2022

Aug 15, 2022
BUY
$174.81 - $241.14 $5,943 - $8,198
34 Added 0.51%
6,757 $1.59 Million
Q1 2022

May 10, 2022
BUY
$166.16 - $213.96 $61,645 - $79,379
371 Added 5.84%
6,723 $1.21 Million
Q4 2021

Feb 14, 2022
BUY
$184.32 - $216.08 $9,584 - $11,236
52 Added 0.83%
6,352 $1.37 Million
Q3 2021

Nov 15, 2021
SELL
$179.86 - $214.88 $49,641 - $59,306
-276 Reduced 4.2%
6,300 $1.16 Million
Q2 2021

Aug 16, 2021
SELL
$170.47 - $211.93 $144,388 - $179,504
-847 Reduced 11.41%
6,576 $1.18 Million
Q1 2021

May 13, 2021
BUY
$153.94 - $174.85 $1.14 Million - $1.3 Million
7,423 New
7,423 $1.24 Million
Q4 2020

Feb 16, 2021
SELL
$101.87 - $151.79 $823,211 - $1.23 Million
-8,081 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$99.9 - $121.13 $807,291 - $978,851
8,081 New
8,081 $816,000

Others Institutions Holding UTHR

# of Institutions
676
Shares Held
42.1M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email